sorafenib to chemotherapy improves the os in older adults with flt3-itd mutated aml
Published 8 years ago • 108 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
2:53
sorafenib to chemotherapy improves the os in older adults with flt3-itd mutated aml
-
2:23
sorafenib for flt3-itd-positive aml
-
6:30
flt3-mutated aml: midostaurin and chemotherapy
-
2:08
crenolanib plus 7 3 chemotherapy in adults with newly diagnosed flt3-mutated aml.
-
5:50
is sorafenib the new standard maintenance treatment for flt3 mutant aml?
-
5:59
frontline lenvatinib vs sorafenib in hcc
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
13:17
what should clinicians know about treating aml in 2023?
-
1:21
gemtuzumab-based induction chemotherapy with midostaurin in flt3-mutated aml
-
3:41
sorafenib maintenace improves outcomes for flt3-itd aml
-
9:44
an update on the quantum-first trial: quizartinib plus chemotherapy in flt3-mutated aml
-
3:27
sorafenib vs placebo in treatment-naïve flt3-itd aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
6:03
quazartinib significantly improves os in flt3-itd positive aml patients relapsed after stem cell
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
3:31
update on quantum-first: quizartinib soc chemotherapy & as continuation therapy in flt3-itd aml
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
3:32
does gilteritinib improve outcome post-midostaurin or -sorafenib treatment?
-
2:47
all about gilteritinib: when is gilteritinib used to treat flt3-positive aml? #aml
-
6:35
costem aml highlights: sct & mrd status, sorafenib maintenance & gilteritinib in flt3 aml
-
7:03
updated results from the soraml trial of sorafenib in younger patients with newly diagnosed aml
-
0:58
flt3 mutation clearance rate in patients with newly diagnosed aml